CancerVax Corporation Drug Fails Late-Stage Skin Cancer Trial
CARLSBAD, CA -- (MARKET WIRE) -- 03/24/2006 -- CancerVax Corporation (NASDAQ: CNVX) announced that data from its Phase 3 clinical trials of Canvaxin™ in the treatment of patients with advanced-stage melanoma will be presented today at the Society for Surgical Oncology's Annual Meeting in San Diego, California.